BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30930982)

  • 21. Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer.
    Zhu CL; Huang Q
    Dig Dis Sci; 2020 Feb; 65(2):489-499. PubMed ID: 31441002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]   [Full Text] [Related]  

  • 23. PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect.
    Gupta A; Ajith A; Singh S; Panday RK; Samaiya A; Shukla S
    Cell Death Dis; 2018 Aug; 9(8):825. PubMed ID: 30068946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.
    Wang CH; Qiao C; Wang RC; Zhou WP
    Mol Med Rep; 2016 Jan; 13(1):123-9. PubMed ID: 26572251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of circRNA chr7:154954255-154998784+ in cancer-associated pancreatic stellate cells promotes the growth and metastasis of pancreatic cancer by targeting the miR-4459/KIAA0513 axis.
    Shao F; Cai M; Fan FF; Huang M; Tao Y; Wang C; Meng FT; Huang Q
    Am J Transl Res; 2020; 12(9):5048-5063. PubMed ID: 33042405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer.
    Song Z; Feng C; Lu Y; Lin Y; Dong C
    Gene; 2018 Feb; 642():43-50. PubMed ID: 29128633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-released exosomal circular RNA circ_0008717 promotes cell tumorigenicity through microRNA-1287-5p/P21-activated kinase 2 (PAK2) axis in non-small cell lung cancer.
    Wang H; Tang Z; Duan J; Zhou C; Xu K; Mu H
    Bioengineered; 2022 Apr; 13(4):8937-8949. PubMed ID: 35333693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA differentiation antagonizing nonprotein coding RNA overexpression accelerates progression and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Chen L; Liu J; Tang T; Zhang YC; Liu MZ; Xu LY; Zhang J
    Onco Targets Ther; 2018; 11():7955-7965. PubMed ID: 30519037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.
    Nuche-Berenguer B; Ramos-Álvarez I; Jensen RT
    Biochim Biophys Acta; 2016 Jun; 1862(6):1122-36. PubMed ID: 26912410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KIF3B Promotes the Proliferation of Pancreatic Cancer.
    Liu ZH; Dong SX; Jia JH; Zhang ZL; Zhen ZG
    Cancer Biother Radiopharm; 2019 Aug; 34(6):355-361. PubMed ID: 31157987
    [No Abstract]   [Full Text] [Related]  

  • 32. P21-activated kinase-2 is a critical mediator of transforming growth factor-β-induced hepatoma cell migration.
    Sato M; Matsuda Y; Wakai T; Kubota M; Osawa M; Fujimaki S; Sanpei A; Takamura M; Yamagiwa S; Aoyagi Y
    J Gastroenterol Hepatol; 2013 Jun; 28(6):1047-55. PubMed ID: 23425030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
    Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
    Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
    Li Q; Wu X; Guo L; Shi J; Li J
    FEBS Open Bio; 2019 Nov; 9(11):1983-1993. PubMed ID: 31587474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
    Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
    Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
    Wang X; Yang B; She Y; Ye Y
    J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
    Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
    Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts.
    Pulkkinen K; Renkema GH; Kirchhoff F; Saksela K
    J Virol; 2004 Dec; 78(23):12773-80. PubMed ID: 15542629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
    Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer.
    Buikhuisen JY; Gomez Barila PM; Cameron K; Suijkerbuijk SJE; Lieftink C; di Franco S; Krotenberg Garcia A; Uceda Castro R; Lenos KJ; Nijman LE; Torang A; Longobardi C; de Jong JH; Dekker D; Stassi G; Vermeulen L; Beijersbergen RL; van Rheenen J; Huveneers S; Medema JP
    J Exp Clin Cancer Res; 2023 Mar; 42(1):56. PubMed ID: 36869386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.